SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 1 — Leonard Nimoy

PatientLeonard Nimoy
Date of birth1943-03-26
IdentifiersMRN HR-ML017-SYN; SSN (made up) 000-17-6604
Document date2026-02-10
AuthorCarla Benedetti, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Subjective

The patient attends this visit for new patient visit for COPD and breathlessness walking any distance. [S]

Objective

FEV1 before bronchodilator: 1.18 L (low); FEV1 after bronchodilator: 1.26 L (low); FEV1 percent predicted after bronchodilator: 46% (low); FVC after bronchodilator: 2.93 L; FEV1/FVC after bronchodilator: 0.43 (low); Blood eosinophil count: 0.18 10*3/uL; Alpha-1 antitrypsin: 138 mg/dL; Hemoglobin: 14.6 g/dL; Creatinine: 0.98 mg/dL; PHQ-9: 3. [S]

Vital Signs

DateMeasureValueUnitProvenance
2026-02-10Body height185cmS
2026-02-10Body weight80kgS
2026-02-10Body mass index (BMI) [Ratio]23.4kg/m2S
2026-02-10Systolic blood pressure132mm[Hg]S
2026-02-10Diastolic blood pressure78mm[Hg]S
2026-02-10Heart rate84/minS
2026-02-10Respiratory rate20/minS
2026-02-10Body temperature36.7CelS
2026-02-10Oxygen saturation in Arterial blood by Pulse oximetry93%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-02-10FEV1 --pre bronchodilation1.18L>=1.95 LLowS
2026-02-10FEV1 --post bronchodilation1.26L>=1.95 LLowS
2026-02-10FEV1 measured/predicted46%>=80%LowS
2026-02-10Forced vital capacity [Volume] Respiratory system --post bronchodilation2.93L>=2.75 LNormalS
2026-02-10FEV1/FVC --post bronchodilation0.43{ratio}GOLD fixed ratio 0.70; post-bronchodilator ratio below 0.70 confirms airflow obstructionLowS
2026-02-10Eosinophils [#/volume] in Blood by Automated count0.1810*3/uL0-0.5 10*3/uLNormalS
2026-02-10Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma138mg/dL90-200 mg/dLNormalS
2026-02-10Hemoglobin [Mass/volume] in Blood14.6g/dL13.5-17.5 g/dLNormalS
2026-02-10Creatinine [Mass/volume] in Serum or Plasma0.98mg/dL0.7-1.3 mg/dLNormalS
2026-02-10Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]3{score}S

Medications

MedicationFrequencyRouteDatesStatusEvidence
Albuterol 90 mcg/actuation inhaler, two inhalations as needed for breathlessness (prescribed by his previous clinician; used once or twice most days before intake)Two inhalations every 4 hours as needed, with a spacerRespiratory tract route2025-09-15activeS
Tiotropium-olodaterol 2.5/2.5 mcg soft mist inhaler, two inhalations once dailyTwo inhalations once each morningRespiratory tract route2026-02-10activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Problems

ProblemClinical statusVerificationCodeProvenance
Chronic obstructive pulmonary disease, GOLD 3 (severe airflow limitation), group B, confirmed on spirometry; synthetic modern classification linked to his publicly disclosed COPDactiveconfirmed J44.9S — Synthetic modern spirometric classification; the COPD diagnosis itself is D from his own public disclosure.
Former smoker, quit about 30 years ago through a cessation programactiveconfirmed Z87.891S — Synthetic modern entry linked to his public account of quitting smoking.

Assessment

Plan of Treatment